Details for New Drug Application (NDA): 212883
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 212883
Tradename: | SILDENAFIL CITRATE |
Applicant: | Ajanta Pharma Ltd |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Pharmacology for NDA: 212883
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 212883
Suppliers and Packaging for NDA: 212883
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 212883 | ANDA | Ajanta Pharma USA Inc. | 27241-175 | 27241-175-29 | 1 POUCH in 1 CARTON (27241-175-29) / 1 BOTTLE in 1 POUCH / 112 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Nov 27, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription